The clinical benefits of rehabilitation in cardiovascular disease are well established. Among cardiovascular disease patients, however, patients with type 2 diabetes mellitus require a distinct approach. Specific challenges to clinicians and healthcare professionals in patients with type 2 diabetes include the prevalence of peripheral and autonomic neuropathy, retinopathy, nephropathy, but also the intake of glucose-lowering medication. In addition, the psychosocial wellbeing, driving ability and/or occupational status can be affected by type 2 diabetes. As a result, the target parameters of cardiovascular rehabilitation and the characteristics of the cardiovascular rehabilitation programme in patients with type 2 diabetes often require significant reconsideration and a multidisciplinary approach. This review explains how to deal with diabetes-associated comorbidities in the intake screening of patients with type 2 diabetes entering a cardiovascular rehabilitation programme. Furthermore, we discuss diabetes-specific target parameters and characteristics of cardiovascular rehabilitation programmes for patients with type 2 diabetes in a multidisciplinary context, including the implementation of guideline-directed medical therapy.
IbanezBJamesSAgewallS, et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2018; 39: 119–177.
2.
RauchBDavosCHDohertyP, et al.The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies – the Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol2016; 23: 1914–1939.
3.
AhmedBDavisHTLaskeyWK. In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000–2010. J Am Heart Assoc2014; 3: e001090.
4.
American Diabetes Association. classification and diagnosis of diabetes: standards of medical care in diabetes – 2019. Diabetes Care2019; 42: S13–S28.
5.
The Task Force for Diabetes, Pre-diabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J Epub ahead of print 31 August 2019. DOI: 10.1093/eurheartj/ehz486.
6.
KeytsmanCDendalePHansenD. Chronotropic incompetence during exercise in type 2 diabetes: aetiology, assessment methodology, prognostic impact and therapy. Sports Med2015; 45: 985–995.
7.
BrubakerPHKitzmanDW. Chronotropic incompetence: causes, consequences, and management. Circulation2011; 123: 1010–1020.
8.
WilkoffBLMillerRE. Exercise testing for chronotropic assessment. Cardiol Clin1992; 10: 705–717.
9.
QiuSHXueCSunZL, et al.Attenuated heart rate recovery predicts risk of incident diabetes: insights from a meta-analysis. Diabet Med2017; 34: 1676–1683.
10.
JollyMABrennanDMChoL. Impact of exercise on heart rate recovery. Circulation2011; 124: 1520–1526.
11.
LievreMMMoulinPThivoletC, et al.Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening. Trials2011; 12: 23.
12.
ZellwegerMJHaafPMaraunM, et al.Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus. Int J Cardiol2017; 244: 37–42.
13.
LyerlyGWSuiXChurchTS, et al.Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus. Circulation2008; 117: 2734–2742.
14.
BelardinelliRLacalapriceFTianoL, et al.Cardiopulmonary exercise testing is more accurate than ECG-stress testing in diagnosing myocardial ischemia in subjects with chest pain. Int J Cardiol2014; 174: 337–342.
15.
GehlingDJCzernikBLEbraheimNA. Orthopedic complications in diabetes. Bone2016; 82: 79–92.
16.
National Institute for Health and Care Excellence. Type 2 diabetes foot problems: Prevention and management of foot problems. 2004. http://guidance.nice.org.uk/CG10 (accessed 5 October 2019).
17.
Global Burden of Disease Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet2019; 393: 1958–1972.
18.
MichaRPenalvoJLCudheaF, et al.Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA2017; 317: 912–924.
19.
RaneKWajngotAWandellPE, et al.Psychosocial problems in patients with newly diagnosed diabetes: number and characteristics. Diabet Res Clin Pract2011; 93: 371–378.
20.
RobertsonSMStanleyMACullyJA, et al.Positive emotional health and diabetes care: concepts, measurement, and clinical implications. Psychosomatics2012; 53: 1–12.
21.
PolonskyWHFisherLHesslerD, et al.Identifying the worries and concerns about hypoglycemia in adults with type 2 diabetes. J Diabet Complic2015; 29: 1171–1176.
22.
HinderSGreenhalghT. “This does my head in”. Ethnographic study of self-management by people with diabetes. BMC Health Serv Res2012; 12: 83.
23.
JohansenC. Barriers to addressing psychological problems in diabetes: perspectives of diabetologists on routine diabetes consultations in Denmark. J Psychol Psychother2014; 4: 2–7.
24.
RadGSBakhtLAFeiziA, et al.Importance of social support in diabetes care. J Educ Health Promot2013; 2: 62.
25.
Young-HymanDde GrootMHill-BriggsF, et al.Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care2016; 39: 2126–2140.
26.
TanXvan EgmondLChapmanCD, et al.Aiding sleep in type 2 diabetes: therapeutic considerations. Lancet Diabetes Endocrinol2018; 6: 60–68.
27.
WangJThorntonJCBariS, et al.Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr2003; 77: 379–384.
28.
MiyataniMYangPThomasS, et al.Bioelectrical impedance and dual-energy x-ray absorptiometry assessments of changes in body composition following exercise in patients with type 2 diabetes mellitus. J Obes2012; 2012: 953060.
29.
SowersJREpsteinMFrohlichED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension2001; 37: 1053–1059.
30.
WilliamsBManciaGSpieringW, et al.2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J2018; 39: 3021–3104.
31.
KramerCKLeitaoCBCananiLH, et al.Blood pressure responses to exercise in type II diabetes mellitus patients with masked hypertension. J Hum Hypertens2009; 23: 620–622.
32.
WeiMGibbonsLWKampertJB, et al.Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med2000; 132: 605–611.
33.
ChurchTSLaMonteMJBarlowCE, et al.Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med2005; 165: 2114–2120.
34.
WarrenJMEkelundUBessonH, et al.Assessment of physical activity – a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil2010; 17: 127–139.
35.
MynarskiWPsurekABorekZ, et al.Declared and real physical activity in patients with type 2 diabetes mellitus as assessed by the International Physical Activity Questionnaire and Caltrac accelerometer monitor: a potential tool for physical activity assessment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract2012; 98: 46–50.
36.
QiuSCaiXChenX, et al.Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials. BMC Med2014; 12: 36.
37.
GuazziMAdamsVConraadsV, et al.EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J2012; 33: 2917–2927.
38.
FangZYSharmanJPrinsJB, et al.Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care2005; 28: 1643–1648.
39.
HansenDDendalePConinxK, et al.The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: a digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol2017; 24: 1017–1031.
40.
KempsHKrankelNDorrM, et al.Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019; 26: 709–727.
41.
LookARGWingRRBolinP, et al.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med2013; 369: 145–154.
42.
UmpierreDRibeiroPASchaanBD, et al.Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia2013; 56: 242–251.
43.
UmpierreDRibeiroPAKramerCK, et al.Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA2011; 305: 1790–1799.
44.
BouleNGHaddadEKennyGP, et al.Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA2001; 286: 1218–1227.
45.
LiuJXZhuLLiPJ, et al.Effectiveness of high-intensity interval training on glycemic control and cardiorespiratory fitness in patients with type 2 diabetes: a systematic review and meta-analysis. Aging Clin Exp Res2019; 31: 575–593.
46.
EggerANiederseerDDiemG, et al.Different types of resistance training in type 2 diabetes mellitus: effects on glycaemic control, muscle mass and strength. Eur J Prev Cardiol2013; 20: 1051–1060.
47.
IshiguroHKodamaSHorikawaC, et al.In search of the ideal resistance training program to improve glycemic control and its indication for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Sports Med2016; 46: 67–77.
48.
DuvivierBMSchaperNCHesselinkMK, et al.Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Diabetologia2017; 60: 490–498.
49.
DempseyPCBlankenshipJMLarsenRN, et al.Interrupting prolonged sitting in type 2 diabetes: nocturnal persistence of improved glycaemic control. Diabetologia2017; 60: 499–507.
50.
HensonJDaviesMJBodicoatDH, et al.Breaking up prolonged sitting with standing or walking attenuates the postprandial metabolic response in postmenopausal women: a randomized acute study. Diabetes Care2016; 39: 130–138.
51.
FrederixICaianiEGDendaleP, et al.ESC e-Cardiology Working Group. Position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol2019; 26: 1166–1177.
52.
InzucchiSEBergenstalRMBuseJB, et al.Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care2015; 38: 140–149.
53.
PonikowskiPJankowskaEA. Hypoglycaemia in diabetic patients: highly undesirable by cardiologists. Eur Heart J2013; 34: 3102–3105.
54.
HansenDPeetersSZwaenepoelB, et al.Exercise assessment and prescription in patients with type 2 diabetes in the private and home care setting: clinical recommendations from AXXON (Belgian Physical Therapy Association). Phys Ther2013; 93: 597–610.
55.
HansenDNiebauerJCornelissenV, et al.Exercise prescription in patients with different combinations of cardiovascular disease risk factors: a consensus statement from the EXPERT Working Group. Sports Med2018; 48: 1781–1797.
56.
HansenDAbreuADohertyP, et al.Dynamic strength training intensity in cardiovascular rehabilitation: is it time to reconsider clinical practice?. Eur J Prev Cardiol2019; 26: 1483–1492.
57.
CornelissenVASmartNA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc2013; 2: e004473.
58.
KelleyGAKelleyKSFranklinB. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J Cardiopulm Rehabil2006; 26: 131–139.
59.
HayashinoYJacksonJLFukumoriN, et al.Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract2012; 98: 349–360.
60.
KodamaSTanakaSSaitoK, et al.Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med2007; 167: 999–1008.
61.
KelleyGAKelleyKS. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med2009; 48: 9–19.
62.
FranzMJVanWormerJJCrainAL, et al.Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc2007; 107: 1755–1767.
63.
GreggEWJakicicJMBlackburnG, et al.Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol2016; 4: 913–921.
64.
AdesPASavagePDTothMJ, et al.High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation2009; 119: 2671–2678.
65.
SwiftDLJohannsenNMLavieCJ, et al.The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis2014; 56: 441–447.
66.
SchwingshacklLDiasSStrasserB, et al.Impact of different training modalities on anthropometric and metabolic characteristics in overweight/obese subjects: a systematic review and network meta-analysis. PLoS One2013; 8: e82853.
67.
HackettDHagstromAD. Effect of overnight fasted exercise on weight loss and body composition: a systematic review and meta-analysis. J Funct Morphol Kinesiol2017; 2: 43.
68.
BesnierFLenclumeVGérardinP, et al.Individualized exercise training at maximal fat oxidation combined with fruit and vegetable-rich diet in overweight or obese women: the LIPOXmax-Réunion Randomized Controlled Trial. PLoS One2015; 10: e0139246.
69.
Lambrinou E, Hansen TB and Beulens JWJ. Life style factors, self-management & Patient empowerment in diabetes care. Eur J Prev Cardiol 2019; 26(2S): 55–63.
70.
KahnRAndersonJE. Improving diabetes care: the model for health care reform. Diabetes Care2009; 32: 1115–1118.
71.
GhoshSBajajSMukhopadhyayP, et al.Diabetes and employment. Int J Diabetes Dev Countries2018; 38: 133–137.
72.
MerendinoJJJr. What factors must one consider when evaluating an individual with diabetes for return to work?. J Occup Environ Med2016; 58: e154–e156.
73.
American Diabetes Association. Diabetes and employment. Diabetes Care2009; 32: S80–S84.
74.
HostiucSNegoiIHostiucM. Diabetes and collision risk. A meta-analysis and meta-regression. Int J Clin Pract2016; 70: 554–568.
75.
GravelingAJFrierBM. Driving and diabetes: are the changes in the European Union licensing regulations fit for purpose?. Br J Diabetes2018; 18: 25–31.
EvertABDennisonMGardnerCD, et al.Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care2019; 42: 731–754.
79.
ChiavaroliLViguilioukENishiSK, et al.DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients2019, pp. 11: E338.
80.
Korsmo-HaugenHKBrurbergKGMannJ, et al.Carbohydrate quantity in the dietary management of type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab2019; 21: 15–27.
81.
AlbisserAMHarrisRIAlbisserJB, et al.The impact of initiatives in education, self-management training, and computer-assisted self-care on outcomes in diabetes disease management. Diabetes Technol Ther2001; 3: 571–579.
82.
FunnellMMAndersonRM. The problem with compliance in diabetes. JAMA2000; 284: 1709.
83.
FunnellMMAndersonRM. Empowerment and self-management of diabetes. Clin Diabetes2004; 22: 123–127.
HeislerMBouknightRRHaywardRA, et al.The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med2003; 17: 243–253.
86.
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care2018; 41: 2669–2270.
87.
LandgrafRKellererMAberleetJ, et al.Therapie des Typ 2 Diabetes. Diabetologie2018; 13: S144–S165.
